 David Mirsky
Concepts (375)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 44 | 2023 | 3174 | 3.490 |
Why?
| | Hydrocephalus | 5 | 2023 | 81 | 2.390 |
Why?
| | Prenatal Diagnosis | 7 | 2022 | 168 | 2.190 |
Why?
| | Stroke | 14 | 2022 | 1047 | 1.710 |
Why?
| | Brain | 15 | 2022 | 2490 | 1.570 |
Why?
| | Neuroimaging | 9 | 2022 | 256 | 1.330 |
Why?
| | Cerebrospinal Fluid Shunts | 2 | 2020 | 31 | 1.320 |
Why?
| | Craniocerebral Trauma | 4 | 2022 | 146 | 1.250 |
Why?
| | Neural Tube Defects | 2 | 2018 | 63 | 1.090 |
Why?
| | Brain Neoplasms | 7 | 2022 | 1022 | 1.080 |
Why?
| | Child | 51 | 2023 | 19129 | 1.030 |
Why?
| | Child Abuse | 4 | 2023 | 466 | 1.000 |
Why?
| | Fetus | 5 | 2022 | 690 | 1.000 |
Why?
| | Nervous System Malformations | 2 | 2023 | 33 | 0.970 |
Why?
| | Central Nervous System Neoplasms | 2 | 2022 | 128 | 0.950 |
Why?
| | Head and Neck Neoplasms | 3 | 2022 | 471 | 0.950 |
Why?
| | Megalencephaly | 1 | 2022 | 15 | 0.870 |
Why?
| | Circle of Willis | 1 | 2022 | 6 | 0.860 |
Why?
| | Dermoid Cyst | 1 | 2022 | 13 | 0.850 |
Why?
| | Epidermal Cyst | 1 | 2022 | 12 | 0.850 |
Why?
| | Contrast Media | 4 | 2022 | 373 | 0.830 |
Why?
| | Retrospective Studies | 29 | 2023 | 12978 | 0.830 |
Why?
| | Nasal Obstruction | 1 | 2021 | 27 | 0.780 |
Why?
| | Neck | 4 | 2022 | 89 | 0.770 |
Why?
| | Infant, Newborn, Diseases | 2 | 2019 | 106 | 0.760 |
Why?
| | Central Nervous System Infections | 2 | 2018 | 39 | 0.750 |
Why?
| | Gadolinium DTPA | 2 | 2019 | 54 | 0.750 |
Why?
| | Ependymoma | 1 | 2022 | 169 | 0.740 |
Why?
| | Intracranial Hemorrhages | 2 | 2019 | 77 | 0.730 |
Why?
| | Tomography, X-Ray Computed | 12 | 2022 | 2436 | 0.730 |
Why?
| | Humans | 91 | 2023 | 118972 | 0.720 |
Why?
| | Temporal Lobe | 1 | 2019 | 90 | 0.690 |
Why?
| | Thrombosis | 1 | 2022 | 309 | 0.680 |
Why?
| | Cavernous Sinus Thrombosis | 2 | 2015 | 9 | 0.680 |
Why?
| | Anatomic Landmarks | 1 | 2018 | 28 | 0.670 |
Why?
| | Infant | 18 | 2023 | 8293 | 0.650 |
Why?
| | Child, Preschool | 25 | 2023 | 9491 | 0.630 |
Why?
| | Occipital Lobe | 1 | 2017 | 23 | 0.620 |
Why?
| | Spinal Cord | 2 | 2021 | 367 | 0.590 |
Why?
| | Cerebral Hemorrhage | 1 | 2017 | 100 | 0.590 |
Why?
| | Facial Injuries | 1 | 2016 | 19 | 0.580 |
Why?
| | Pediatrics | 4 | 2019 | 985 | 0.580 |
Why?
| | Carotid Stenosis | 2 | 2015 | 75 | 0.570 |
Why?
| | Head | 2 | 2019 | 89 | 0.570 |
Why?
| | Frontal Lobe | 1 | 2017 | 148 | 0.570 |
Why?
| | Craniopharyngioma | 3 | 2023 | 70 | 0.550 |
Why?
| | Brain Diseases | 2 | 2020 | 140 | 0.550 |
Why?
| | Societies, Medical | 6 | 2022 | 703 | 0.550 |
Why?
| | Tissue Adhesions | 1 | 2015 | 31 | 0.550 |
Why?
| | Spinal Injuries | 3 | 2022 | 53 | 0.540 |
Why?
| | Ultrasonography, Prenatal | 3 | 2022 | 227 | 0.540 |
Why?
| | Lymphatic Abnormalities | 2 | 2012 | 18 | 0.540 |
Why?
| | Cerebral Infarction | 1 | 2015 | 45 | 0.530 |
Why?
| | Craniofacial Abnormalities | 2 | 2012 | 58 | 0.520 |
Why?
| | Central Nervous System Diseases | 1 | 2015 | 64 | 0.520 |
Why?
| | Hypothalamus | 1 | 2015 | 155 | 0.510 |
Why?
| | Female | 43 | 2022 | 61564 | 0.500 |
Why?
| | Infant, Newborn | 14 | 2022 | 5255 | 0.490 |
Why?
| | Dandy-Walker Syndrome | 2 | 2023 | 7 | 0.460 |
Why?
| | Proto-Oncogene Proteins B-raf | 4 | 2023 | 202 | 0.450 |
Why?
| | Goiter | 1 | 2012 | 3 | 0.440 |
Why?
| | Stomatognathic Diseases | 1 | 2012 | 4 | 0.440 |
Why?
| | Pregnancy | 11 | 2022 | 5690 | 0.420 |
Why?
| | Magnetic Resonance Angiography | 3 | 2019 | 210 | 0.400 |
Why?
| | Fetal Diseases | 1 | 2012 | 148 | 0.390 |
Why?
| | Male | 34 | 2022 | 57801 | 0.390 |
Why?
| | Brain Ischemia | 3 | 2022 | 310 | 0.390 |
Why?
| | Sinusitis | 3 | 2018 | 175 | 0.390 |
Why?
| | Sacrum | 3 | 2018 | 67 | 0.370 |
Why?
| | Diagnosis, Differential | 7 | 2019 | 1384 | 0.360 |
Why?
| | Postoperative Complications | 2 | 2018 | 2235 | 0.360 |
Why?
| | Pituitary Neoplasms | 2 | 2023 | 165 | 0.360 |
Why?
| | Infarction, Middle Cerebral Artery | 3 | 2022 | 41 | 0.350 |
Why?
| | Hypothalamic Diseases | 2 | 2022 | 18 | 0.350 |
Why?
| | Anorectal Malformations | 2 | 2021 | 98 | 0.330 |
Why?
| | Emergency Medical Services | 1 | 2015 | 589 | 0.320 |
Why?
| | Mitochondrial Diseases | 2 | 2020 | 79 | 0.320 |
Why?
| | Evidence-Based Medicine | 6 | 2022 | 693 | 0.320 |
Why?
| | Adolescent | 17 | 2023 | 18480 | 0.310 |
Why?
| | Teratoma | 2 | 2019 | 92 | 0.300 |
Why?
| | Prevalence | 3 | 2022 | 2326 | 0.300 |
Why?
| | Cerebrovascular Disorders | 2 | 2020 | 86 | 0.290 |
Why?
| | Muscular Diseases | 2 | 2020 | 107 | 0.290 |
Why?
| | Priapism | 1 | 2005 | 9 | 0.270 |
Why?
| | Prenatal Care | 3 | 2022 | 252 | 0.270 |
Why?
| | Penis | 1 | 2005 | 37 | 0.270 |
Why?
| | Hematoma, Subdural | 2 | 2022 | 17 | 0.270 |
Why?
| | Chloroquine | 2 | 2017 | 64 | 0.260 |
Why?
| | Gestational Age | 3 | 2022 | 765 | 0.260 |
Why?
| | Vertebral Artery Dissection | 2 | 2022 | 19 | 0.260 |
Why?
| | Embolization, Therapeutic | 1 | 2005 | 192 | 0.230 |
Why?
| | Ventriculoperitoneal Shunt | 2 | 2020 | 33 | 0.230 |
Why?
| | Indoles | 2 | 2017 | 316 | 0.230 |
Why?
| | Physical Abuse | 1 | 2023 | 32 | 0.220 |
Why?
| | Surface Plasmon Resonance | 1 | 2022 | 85 | 0.220 |
Why?
| | Neck Injuries | 1 | 2022 | 20 | 0.220 |
Why?
| | Central Nervous System Vascular Malformations | 1 | 2022 | 23 | 0.220 |
Why?
| | Constriction, Pathologic | 2 | 2021 | 203 | 0.220 |
Why?
| | Pyrimidinones | 1 | 2023 | 86 | 0.210 |
Why?
| | Hypothalamic Neoplasms | 1 | 2022 | 10 | 0.210 |
Why?
| | Sulfonamides | 2 | 2017 | 445 | 0.210 |
Why?
| | Migraine Disorders | 1 | 2023 | 79 | 0.210 |
Why?
| | Pyridones | 1 | 2023 | 119 | 0.210 |
Why?
| | Autophagy | 2 | 2017 | 315 | 0.210 |
Why?
| | Cysts | 1 | 2022 | 93 | 0.210 |
Why?
| | Neuroblastoma | 1 | 2022 | 135 | 0.200 |
Why?
| | Neoplasms, Germ Cell and Embryonal | 1 | 2022 | 60 | 0.200 |
Why?
| | Epilepsy | 2 | 2016 | 290 | 0.200 |
Why?
| | White Matter | 1 | 2023 | 115 | 0.200 |
Why?
| | Intracranial Aneurysm | 1 | 2022 | 99 | 0.200 |
Why?
| | Methionine | 1 | 2021 | 145 | 0.200 |
Why?
| | Meningomyelocele | 1 | 2021 | 51 | 0.200 |
Why?
| | Nasal Cavity | 1 | 2021 | 47 | 0.190 |
Why?
| | Vitamin B 12 | 1 | 2021 | 115 | 0.190 |
Why?
| | Pituitary Diseases | 1 | 2020 | 23 | 0.190 |
Why?
| | Sutures | 1 | 2021 | 61 | 0.190 |
Why?
| | Mitochondrial Proton-Translocating ATPases | 1 | 2020 | 18 | 0.190 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2020 | 35 | 0.190 |
Why?
| | Arnold-Chiari Malformation | 1 | 2020 | 30 | 0.190 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2020 | 12 | 0.190 |
Why?
| | Leigh Disease | 1 | 2020 | 17 | 0.190 |
Why?
| | Quinone Reductases | 1 | 2020 | 15 | 0.190 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2020 | 66 | 0.180 |
Why?
| | Pituitary Gland | 1 | 2020 | 163 | 0.180 |
Why?
| | Hydrogen Sulfide | 1 | 2020 | 40 | 0.180 |
Why?
| | Spasms, Infantile | 1 | 2021 | 104 | 0.180 |
Why?
| | Tyrosine | 1 | 2020 | 233 | 0.180 |
Why?
| | Sequence Analysis, DNA | 2 | 2020 | 755 | 0.180 |
Why?
| | RNA, Transfer | 1 | 2020 | 119 | 0.180 |
Why?
| | DNA, Mitochondrial | 1 | 2020 | 187 | 0.170 |
Why?
| | Central Nervous System Viral Diseases | 1 | 2020 | 63 | 0.170 |
Why?
| | Optic Nerve Neoplasms | 1 | 2019 | 10 | 0.170 |
Why?
| | Optic Chiasm | 1 | 2019 | 18 | 0.170 |
Why?
| | Taenia solium | 1 | 2018 | 5 | 0.170 |
Why?
| | Neurocysticercosis | 1 | 2018 | 6 | 0.170 |
Why?
| | Foramen Magnum | 1 | 2018 | 10 | 0.170 |
Why?
| | Ilium | 1 | 2018 | 29 | 0.170 |
Why?
| | United States | 10 | 2021 | 12555 | 0.170 |
Why?
| | Occipital Bone | 1 | 2018 | 20 | 0.160 |
Why?
| | Sphenoid Bone | 1 | 2018 | 16 | 0.160 |
Why?
| | Soft Tissue Neoplasms | 1 | 2019 | 93 | 0.160 |
Why?
| | Skull Base | 1 | 2018 | 44 | 0.160 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2019 | 109 | 0.160 |
Why?
| | Reference Values | 1 | 2019 | 774 | 0.160 |
Why?
| | Epilepsies, Partial | 1 | 2018 | 28 | 0.160 |
Why?
| | Toxoplasmosis | 1 | 2018 | 31 | 0.160 |
Why?
| | Area Under Curve | 1 | 2018 | 296 | 0.160 |
Why?
| | Radiation Dosage | 1 | 2019 | 147 | 0.160 |
Why?
| | Adenoidectomy | 1 | 2018 | 60 | 0.160 |
Why?
| | Fecal Incontinence | 1 | 2018 | 76 | 0.160 |
Why?
| | Intracranial Arterial Diseases | 1 | 2017 | 6 | 0.150 |
Why?
| | Mitochondria | 2 | 2020 | 786 | 0.150 |
Why?
| | Olfaction Disorders | 1 | 2018 | 47 | 0.150 |
Why?
| | Central Nervous System | 2 | 2022 | 245 | 0.150 |
Why?
| | Sensitivity and Specificity | 2 | 2020 | 1795 | 0.150 |
Why?
| | Drug Resistant Epilepsy | 1 | 2018 | 48 | 0.150 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2018 | 131 | 0.150 |
Why?
| | Common Data Elements | 1 | 2017 | 9 | 0.150 |
Why?
| | Radiology | 1 | 2020 | 199 | 0.150 |
Why?
| | Herpes Simplex | 1 | 2018 | 90 | 0.150 |
Why?
| | Coccyx | 1 | 2017 | 5 | 0.150 |
Why?
| | Choroid Neoplasms | 1 | 2017 | 6 | 0.150 |
Why?
| | Seizures | 2 | 2021 | 345 | 0.150 |
Why?
| | ROC Curve | 1 | 2018 | 473 | 0.150 |
Why?
| | Fetal Movement | 1 | 2016 | 7 | 0.150 |
Why?
| | Tertiary Care Centers | 1 | 2017 | 119 | 0.150 |
Why?
| | Cerebral Arteries | 1 | 2017 | 56 | 0.150 |
Why?
| | Fetal Monitoring | 1 | 2016 | 18 | 0.150 |
Why?
| | Diazepam | 1 | 2016 | 23 | 0.150 |
Why?
| | Zika Virus Infection | 1 | 2018 | 85 | 0.150 |
Why?
| | Anti-Anxiety Agents | 1 | 2016 | 38 | 0.140 |
Why?
| | Osteomyelitis | 1 | 2018 | 110 | 0.140 |
Why?
| | Imaging, Three-Dimensional | 2 | 2019 | 499 | 0.140 |
Why?
| | Spondylolysis | 1 | 2016 | 7 | 0.140 |
Why?
| | Organ Size | 1 | 2017 | 460 | 0.140 |
Why?
| | Olfactory Bulb | 1 | 2018 | 125 | 0.140 |
Why?
| | Positron-Emission Tomography | 1 | 2018 | 298 | 0.140 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2020 | 709 | 0.140 |
Why?
| | Balamuthia mandrillaris | 1 | 2015 | 4 | 0.140 |
Why?
| | Amebiasis | 1 | 2015 | 5 | 0.140 |
Why?
| | Genome, Microbial | 1 | 2015 | 7 | 0.140 |
Why?
| | Third Ventricle | 1 | 2015 | 14 | 0.140 |
Why?
| | Intracranial Thrombosis | 1 | 2015 | 17 | 0.140 |
Why?
| | Fracture Fixation | 1 | 2016 | 81 | 0.140 |
Why?
| | Hamartoma | 1 | 2015 | 20 | 0.140 |
Why?
| | Cytomegalovirus Infections | 1 | 2018 | 187 | 0.140 |
Why?
| | Genome, Mitochondrial | 1 | 2015 | 26 | 0.140 |
Why?
| | Antibiotic Prophylaxis | 1 | 2016 | 100 | 0.140 |
Why?
| | Headache | 3 | 2023 | 128 | 0.140 |
Why?
| | Eye Infections, Fungal | 1 | 2015 | 7 | 0.140 |
Why?
| | Endocrine System Diseases | 1 | 2015 | 32 | 0.140 |
Why?
| | Infant, Premature, Diseases | 1 | 2017 | 93 | 0.130 |
Why?
| | Orbital Cellulitis | 1 | 2015 | 14 | 0.130 |
Why?
| | Encephalomyelitis, Acute Disseminated | 1 | 2015 | 12 | 0.130 |
Why?
| | Perioperative Care | 1 | 2016 | 132 | 0.130 |
Why?
| | Onchocerciasis | 1 | 2015 | 7 | 0.130 |
Why?
| | Eye Infections, Bacterial | 1 | 2015 | 26 | 0.130 |
Why?
| | Pyridoxine | 1 | 2015 | 26 | 0.130 |
Why?
| | Software | 1 | 2020 | 613 | 0.130 |
Why?
| | Spinal Cord Diseases | 1 | 2015 | 39 | 0.130 |
Why?
| | Vitamin B Complex | 1 | 2015 | 37 | 0.130 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2017 | 671 | 0.130 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 348 | 0.130 |
Why?
| | Coronavirus Infections | 1 | 2020 | 339 | 0.130 |
Why?
| | Emergencies | 1 | 2015 | 153 | 0.130 |
Why?
| | Paralysis | 1 | 2015 | 67 | 0.130 |
Why?
| | Cranial Nerve Diseases | 1 | 2014 | 42 | 0.130 |
Why?
| | Bone Neoplasms | 1 | 2017 | 199 | 0.130 |
Why?
| | Paraplegia | 1 | 2014 | 60 | 0.120 |
Why?
| | Brain Injuries, Traumatic | 1 | 2019 | 318 | 0.120 |
Why?
| | Cerebral Arterial Diseases | 1 | 2014 | 43 | 0.120 |
Why?
| | Antineoplastic Agents | 2 | 2017 | 1974 | 0.120 |
Why?
| | Fetal Therapies | 1 | 2014 | 32 | 0.120 |
Why?
| | Lumbar Vertebrae | 1 | 2016 | 215 | 0.120 |
Why?
| | Hippocampus | 1 | 2018 | 735 | 0.120 |
Why?
| | Encephalitis | 1 | 2015 | 129 | 0.120 |
Why?
| | Arginine | 1 | 2015 | 249 | 0.120 |
Why?
| | Neuromyelitis Optica | 1 | 2015 | 112 | 0.120 |
Why?
| | Nervous System Diseases | 1 | 2017 | 261 | 0.120 |
Why?
| | Adult | 7 | 2023 | 31512 | 0.120 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2014 | 59 | 0.120 |
Why?
| | Neurodevelopmental Disorders | 1 | 2015 | 116 | 0.120 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1474 | 0.120 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2015 | 220 | 0.120 |
Why?
| | Enterovirus D, Human | 1 | 2014 | 76 | 0.110 |
Why?
| | Lysine | 1 | 2015 | 248 | 0.110 |
Why?
| | Otitis Media | 1 | 2015 | 146 | 0.110 |
Why?
| | Developmental Disabilities | 1 | 2015 | 247 | 0.110 |
Why?
| | Pharyngeal Diseases | 1 | 2012 | 15 | 0.110 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2062 | 0.110 |
Why?
| | Logistic Models | 1 | 2017 | 1901 | 0.110 |
Why?
| | HIV Infections | 2 | 2018 | 2459 | 0.110 |
Why?
| | Glucocorticoids | 1 | 2016 | 545 | 0.110 |
Why?
| | Enterovirus Infections | 1 | 2014 | 164 | 0.110 |
Why?
| | Cranial Fossa, Posterior | 2 | 2022 | 17 | 0.100 |
Why?
| | Amino Acids | 1 | 2015 | 464 | 0.100 |
Why?
| | Case-Control Studies | 1 | 2018 | 3171 | 0.100 |
Why?
| | Mutation | 5 | 2021 | 3457 | 0.100 |
Why?
| | Incidence | 1 | 2017 | 2424 | 0.100 |
Why?
| | Electron Transport Complex IV | 2 | 2020 | 53 | 0.090 |
Why?
| | Brain Injuries | 1 | 2015 | 484 | 0.090 |
Why?
| | Anti-Bacterial Agents | 2 | 2016 | 1510 | 0.090 |
Why?
| | Disease Progression | 1 | 2017 | 2490 | 0.090 |
Why?
| | Herpesvirus 3, Human | 1 | 2014 | 389 | 0.090 |
Why?
| | Cerebellum | 2 | 2022 | 203 | 0.090 |
Why?
| | Herpes Zoster | 1 | 2014 | 336 | 0.090 |
Why?
| | Physical Examination | 2 | 2023 | 243 | 0.090 |
Why?
| | Brain Stem | 2 | 2023 | 104 | 0.090 |
Why?
| | Ultrasonography | 2 | 2021 | 716 | 0.090 |
Why?
| | Cervical Vertebrae | 2 | 2022 | 115 | 0.080 |
Why?
| | Prognosis | 3 | 2023 | 3443 | 0.070 |
Why?
| | Cerebrospinal Fluid | 2 | 2018 | 93 | 0.070 |
Why?
| | Family | 2 | 2021 | 585 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2674 | 0.070 |
Why?
| | Risk Factors | 4 | 2022 | 9000 | 0.070 |
Why?
| | Recurrence | 2 | 2022 | 975 | 0.070 |
Why?
| | Cohort Studies | 1 | 2015 | 5116 | 0.070 |
Why?
| | Follow-Up Studies | 3 | 2022 | 4596 | 0.070 |
Why?
| | Drug Synergism | 2 | 2017 | 339 | 0.060 |
Why?
| | Angiography | 1 | 2005 | 185 | 0.060 |
Why?
| | Endarterectomy, Carotid | 1 | 2004 | 42 | 0.060 |
Why?
| | Spinal Fractures | 1 | 2005 | 77 | 0.060 |
Why?
| | Young Adult | 2 | 2018 | 10793 | 0.060 |
Why?
| | Radiography, Interventional | 1 | 2004 | 113 | 0.060 |
Why?
| | Algorithms | 2 | 2022 | 1541 | 0.060 |
Why?
| | Carotid Arteries | 1 | 2004 | 184 | 0.060 |
Why?
| | Phenotype | 2 | 2021 | 3003 | 0.060 |
Why?
| | Ataxia | 1 | 2022 | 38 | 0.050 |
Why?
| | Middle Cerebral Artery | 1 | 2022 | 30 | 0.050 |
Why?
| | Cranial Sinuses | 1 | 2022 | 13 | 0.050 |
Why?
| | Prospective Studies | 3 | 2021 | 6471 | 0.050 |
Why?
| | Wounds, Gunshot | 1 | 2005 | 176 | 0.050 |
Why?
| | Vertebral Artery | 1 | 2022 | 27 | 0.050 |
Why?
| | Siblings | 1 | 2023 | 235 | 0.050 |
Why?
| | 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2021 | 16 | 0.050 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 1 | 2021 | 19 | 0.050 |
Why?
| | Metabolism, Inborn Errors | 1 | 2021 | 38 | 0.050 |
Why?
| | Forkhead Transcription Factors | 1 | 2022 | 182 | 0.050 |
Why?
| | Retinal Hemorrhage | 1 | 2021 | 18 | 0.050 |
Why?
| | Homocysteine | 1 | 2021 | 137 | 0.050 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2021 | 152 | 0.050 |
Why?
| | Stents | 1 | 2004 | 457 | 0.050 |
Why?
| | Neuroradiography | 1 | 2020 | 3 | 0.050 |
Why?
| | Radiologists | 1 | 2020 | 38 | 0.050 |
Why?
| | Early Diagnosis | 1 | 2021 | 230 | 0.050 |
Why?
| | Preoperative Period | 1 | 2020 | 110 | 0.050 |
Why?
| | Radiography | 1 | 2023 | 861 | 0.050 |
Why?
| | Anal Canal | 1 | 2021 | 83 | 0.050 |
Why?
| | Acidosis, Lactic | 1 | 2020 | 29 | 0.050 |
Why?
| | Oxidative Phosphorylation | 1 | 2020 | 156 | 0.050 |
Why?
| | Reproducibility of Results | 2 | 2019 | 2874 | 0.050 |
Why?
| | Decompression, Surgical | 1 | 2020 | 97 | 0.040 |
Why?
| | Sacrococcygeal Region | 1 | 2019 | 5 | 0.040 |
Why?
| | Homozygote | 1 | 2020 | 190 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2020 | 276 | 0.040 |
Why?
| | Skull Fractures | 1 | 2019 | 30 | 0.040 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 58 | 0.040 |
Why?
| | Radiation Exposure | 1 | 2019 | 44 | 0.040 |
Why?
| | Antibodies, Helminth | 1 | 2018 | 11 | 0.040 |
Why?
| | Diaper Rash | 1 | 2018 | 4 | 0.040 |
Why?
| | Sheep | 1 | 2021 | 764 | 0.040 |
Why?
| | Signal-To-Noise Ratio | 1 | 2019 | 59 | 0.040 |
Why?
| | Kallmann Syndrome | 1 | 2018 | 9 | 0.040 |
Why?
| | Hemispherectomy | 1 | 2018 | 3 | 0.040 |
Why?
| | Urinary Bladder, Neurogenic | 1 | 2018 | 32 | 0.040 |
Why?
| | Weight Gain | 1 | 2022 | 493 | 0.040 |
Why?
| | Nasopharyngeal Neoplasms | 1 | 2018 | 18 | 0.040 |
Why?
| | Cell Line, Tumor | 2 | 2017 | 2851 | 0.040 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 79 | 0.040 |
Why?
| | Urinary Incontinence | 1 | 2018 | 61 | 0.040 |
Why?
| | Leukocyte Count | 1 | 2018 | 305 | 0.040 |
Why?
| | Cell Proliferation | 2 | 2017 | 2275 | 0.040 |
Why?
| | Constipation | 1 | 2018 | 76 | 0.040 |
Why?
| | Overweight | 1 | 2022 | 502 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2020 | 1012 | 0.040 |
Why?
| | Meningitis | 1 | 2018 | 74 | 0.040 |
Why?
| | National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2017 | 3 | 0.040 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2020 | 453 | 0.040 |
Why?
| | Diagnostic Imaging | 1 | 2020 | 294 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 940 | 0.040 |
Why?
| | Trauma Centers | 1 | 2019 | 388 | 0.040 |
Why?
| | Eosinophilia | 1 | 2018 | 184 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2019 | 749 | 0.040 |
Why?
| | Rhinitis | 1 | 2018 | 129 | 0.040 |
Why?
| | Age of Onset | 1 | 2018 | 467 | 0.040 |
Why?
| | Kinetics | 1 | 2020 | 1624 | 0.040 |
Why?
| | Models, Theoretical | 1 | 2020 | 556 | 0.040 |
Why?
| | Labor, Obstetric | 1 | 2016 | 53 | 0.040 |
Why?
| | Wounds, Nonpenetrating | 1 | 2019 | 285 | 0.040 |
Why?
| | Oximetry | 1 | 2016 | 84 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2023 | 9342 | 0.030 |
Why?
| | Electroencephalography | 1 | 2018 | 387 | 0.030 |
Why?
| | Mucormycosis | 1 | 2015 | 20 | 0.030 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2016 | 105 | 0.030 |
Why?
| | Diet Therapy | 1 | 2015 | 38 | 0.030 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2015 | 60 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1390 | 0.030 |
Why?
| | Metagenomics | 1 | 2015 | 134 | 0.030 |
Why?
| | Neurosurgical Procedures | 1 | 2016 | 164 | 0.030 |
Why?
| | Body Mass Index | 1 | 2022 | 2092 | 0.030 |
Why?
| | Data Collection | 1 | 2017 | 658 | 0.030 |
Why?
| | Visual Acuity | 1 | 2015 | 272 | 0.030 |
Why?
| | Venous Thrombosis | 1 | 2015 | 147 | 0.030 |
Why?
| | Cell Survival | 1 | 2017 | 1047 | 0.030 |
Why?
| | Streptococcal Infections | 1 | 2015 | 141 | 0.030 |
Why?
| | Infant, Premature | 1 | 2017 | 480 | 0.030 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 190 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2014 | 381 | 0.030 |
Why?
| | Animals | 3 | 2021 | 33381 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 4552 | 0.030 |
Why?
| | Acute Disease | 1 | 2015 | 940 | 0.030 |
Why?
| | Branchial Region | 1 | 2012 | 34 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 1868 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 965 | 0.030 |
Why?
| | Quality of Life | 1 | 2023 | 2366 | 0.030 |
Why?
| | Disease Outbreaks | 1 | 2014 | 322 | 0.030 |
Why?
| | Pandemics | 1 | 2020 | 1355 | 0.030 |
Why?
| | Dietary Supplements | 1 | 2015 | 467 | 0.020 |
Why?
| | Age Factors | 1 | 2018 | 2995 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2020 | 1515 | 0.020 |
Why?
| | Staphylococcal Infections | 1 | 2015 | 346 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2014 | 1125 | 0.020 |
Why?
| | Colorado | 1 | 2021 | 4196 | 0.020 |
Why?
| | Biomedical Research | 1 | 2017 | 612 | 0.020 |
Why?
| | Research Design | 1 | 2017 | 969 | 0.020 |
Why?
| | Length of Stay | 1 | 2015 | 1032 | 0.020 |
Why?
| | Anxiety | 1 | 2016 | 845 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 2746 | 0.020 |
Why?
| | Time Factors | 1 | 2019 | 6412 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2018 | 4708 | 0.020 |
Why?
| | Aged | 2 | 2019 | 19657 | 0.020 |
Why?
| | Polymethyl Methacrylate | 1 | 2005 | 20 | 0.020 |
Why?
| | Catheterization | 1 | 2004 | 163 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 27617 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2005 | 6561 | 0.010 |
Why?
|
|
Mirsky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|